These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27254284)

  • 21. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
    Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
    BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis.
    Luo HQ; Wang Y; Ren J; Zhang QY; Chen Y; Chen MH; Huang NX; Wu MH; Tang XD; Li XY
    Sci Rep; 2024 Mar; 14(1):6681. PubMed ID: 38509141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy.
    Zhang JX; Qian D; Wang FW; Liao DZ; Wei JH; Tong ZT; Fu J; Huang XX; Liao YJ; Deng HX; Zeng YX; Xie D; Mai SJ
    Cancer Lett; 2013 Feb; 329(1):91-8. PubMed ID: 23142283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2.
    Yuan TZ; Zhang HH; Lin XL; Yu JX; Yang QX; Liang Y; Deng J; Huang LJ; Zhang XP
    Mol Med Rep; 2017 Apr; 15(4):2223-2228. PubMed ID: 28260044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
    Wang Y; Cheng N; Luo J
    J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chloroquine enhances cisplatin-induced apoptosis of nasopharyngeal carcinoma cells by inhibiting autophagy via upregulating miR129].
    Zhang H; Yu Y; Cai W; Lu H; He R; Zhang R; Pei F; Wang X; Fang Y; Wei F
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Mar; 40(3):361-369. PubMed ID: 32376584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype.
    Su Z; Li G; Liu C; Ren S; Tian Y; Liu Y; Qiu Y
    Oncol Rep; 2016 Jul; 36(1):72-8. PubMed ID: 27108809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined application of cisplatin and celecoxib inhibits the proliferation and promotes apoptosis of nasopharyngeal carcinoma cells resistant to cisplatin].
    Chen J; Liu S; Li Q; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):203-6, 211. PubMed ID: 25652863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
    Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
    Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
    Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
    Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Has‑miR‑125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53‑dependent manner by targeting p53 mRNA.
    Chen JJ; Liu SX; Chen MZ; Zhao ZY
    Mol Med Rep; 2015 Sep; 12(3):3569-3574. PubMed ID: 26017674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
    Zhao Y; Wang P; Wu Q
    Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capsaicin enhances cisplatin-induced anti-metastasis of nasopharyngeal carcinoma by inhibiting EMT and ERK signaling via serpin family B member 2.
    Xu Y; Kong W; Zhao S; Xiong D; Wang Y
    Carcinogenesis; 2024 Aug; 45(8):556-568. PubMed ID: 38756095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].
    Xie FY; Zou GR; Hu WH; Qi SN; Peng M; Li JS
    Ai Zheng; 2009 Mar; 28(3):279-85. PubMed ID: 19619443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of MACC1 expression enhances cisplatin sensitivity in SKOV-3/DDP cells.
    Chen ZM; Shi HR; Li X; Deng YX; Zhang RT
    Genet Mol Res; 2015 Dec; 14(4):17134-44. PubMed ID: 26681060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.
    Wu P; Tang Y; He J; Qi L; Jiang W; Zhao S
    Oncol Rep; 2013 Oct; 30(4):1807-13. PubMed ID: 23877130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of ubiquitous mitochondrial creatine kinase on cisplatin sensitivity of human nasopharyngeal carcinoma cell line CNE-1].
    Lan RL; Huang F; Chen RQ; Wang Z; Chen JY; Lin JA; Fu LX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jul; 53(7):524-529. PubMed ID: 30032496
    [No Abstract]   [Full Text] [Related]  

  • 38. Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.
    Zeng Q; Wang Z; Liu C; Gong Z; Yang L; Jiang L; Ma Z; Qian Y; Yang Y; Kang H; Hong S; Bu Y; Hu G
    Mol Cell Biochem; 2016 Jul; 418(1-2):137-46. PubMed ID: 27334757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.
    Li S; Zhang X; Zhang R; Liang Z; Liao W; Du Z; Gao C; Liu F; Fan Y; Hong H
    Cell Cycle; 2017; 16(17):1601-1610. PubMed ID: 28749195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway.
    Liu ZL; Jin BJ; Cheng CG; Zhang FX; Wang SW; Wang Y; Wu B
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5370-5377. PubMed ID: 29243778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.